CN Stock MarketDetailed Quotes

002773 Chengdu Kanghong Pharmaceutical Group

Watchlist
  • 19.95
  • -0.22-1.09%
Noon Break Dec 5 11:30 CST
18.35BMarket Cap15.38P/E (TTM)

About Chengdu Kanghong Pharmaceutical Group Company

The company was founded in 1996, has advanced R&D centers and standard industrial production bases, and a marketing network all over the country. The company's main business is R&D, production and sales of pharmaceuticals (including biological products, proprietary Chinese medicines, chemicals) and medical devices (mainly ophthalmic medical devices). The main products are: compacipril ophthalmic injections, hepatic relief capsules, Songling Xuemaikang capsules, Qiuoxin capsules, cholestasis capsules, Yiqing capsules, venlafaxine hydrochloride sustained-release tablets, aripiprazole oral solution, mosapride citrate tablets, moxapride citrate tablets, dzopiclone tablets, etc. Corporate honors include “Innovative Drug with the Most Clinical Value”, the 5th “China Industry Award”, and the China Patent Gold Award.

Company Profile

Short Name-A康弘药业
Symbol-A002773
Company NameChengdu Kanghong Pharmaceutical Group Co., Ltd
Listing DateJun 26, 2015
Issue Price13.62
Shares Offered45.60M share(s)
FoundedOct 3, 1996
Listed ExchangeSZ Stock Exchange
Legal Representativezunhong ke
General Managerxiao ke
Secretarykang deng
Accounting FirmShinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
Securities Representativegaolei liu
Legal CounselBeijing Commerce (Shenzhen) Law Firm
Employees1052
Phone028-87502055
Office AddressNo. 108 Shuxi Road, Jinniu District, Chengdu
Zip Code610037
Registered AddressNo. 108, Shuxi Road, Jinniu District, Chengdu, Sichuan
Fax028-87513956
Emailkhdm@cnkh.com
Business License510100000012344
BusinessR&D, production, sales and socio-economic information consulting of pharmaceuticals and medical devices; import and export of goods and technology. (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments).

Company Executives

  • Name
  • Position
  • Salary
  • zunhong ke
  • Chairman, Directors, Nomination Committee Members, Audit Committee Members, Chairman of the Strategy Committee
  • 1.32M
  • zhirong zhang
  • Directors
  • --
  • xiao ke
  • Directors, President, Strategy Committee Member
  • 2.05M
  • jinqun yin
  • Directors, VP, Strategy Committee Member
  • 5.85M
  • lin wang
  • Directors, Strategy Committee Member
  • --
  • jianrong zhong
  • Directors, VP, Head of the Internal Audit Department, Member of the Remuneration and Assessment Committee
  • 1.43M
  • demin zhou
  • Independent Directors, Strategy Committee Member, Chairman of the Nomination Committee
  • 50.00K
  • nan xu
  • Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee
  • 50.00K
  • hongguang deng
  • Independent Directors, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
  • 50.00K
  • kang deng
  • Board Secretary
  • 1.38M
  • gaolei liu
  • Securities Affairs Representative
  • --
  • wenxian gong
  • Chairman of the Supervisory Board, Shareholder Supervisors
  • 600.00K
  • yanmei cheng
  • Auditors
  • 199.00K
  • jing ni
  • VP
  • 4.71M
  • yanhua xu
  • VP
  • 3.49M
  • jianjun zhong
  • VP, Chief Financial Officer
  • 3.00M
  • yinying yang
  • Employee Supervisors
  • 490.90K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data